FDA approves once‑weekly Sogroya for wider paediatric use
New authorisation extends treatment to children with ISS, SGA and Noonan syndrome
Read More
Author: John Pinching
SolasCure trial shows faster healing with Aurase Wound Gel
Phase 2 study reports significantly accelerated debridement and wound repair in venous leg ulcers
Read More
Gilead data show investigational HIV combination maintains viral suppression
New phase 3 results highlight potential alternative for adults switching from complex regimens
Read More
Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
More than 200 participants enrolled as company targets topline data by end of 2026
Read More
MHRA approves imlunestrant tosylate as new breast cancer treatment
Oral therapy authorised for ER‑positive, HER2‑negative metastatic disease with ESR1 mutations
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
